CG Oncology (CGON) Times Interest Earned (2023 - 2026)
CG Oncology (CGON) posted Times Interest Earned of -$0.17 for Q1 2026, up 99.93% on a QoQ basis from -$237.56 in Q4 2025, and up 64.13% year-over-year from -$0.11 in Q1 2025.
CG Oncology (CGON) Times Interest Earned (2023 - 2026) Analysis & Trends
CG Oncology's Times Interest Earned history runs 4 years deep, the most recent figure standing at -$0.17 for Q1 2026.
- Quarterly Times Interest Earned rose 64.13% year-over-year to -$0.17 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.56 (up 63.53% YoY) and the FY2025 annual result came in at -$0.96, up 9.37% from the prior year.
- Times Interest Earned was -$0.17 for Q1 2026 at CG Oncology, up from -$237.56 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.1 in Q1 2024 and bottomed at -$634.15 in Q4 2024.
- A 4-year average of -$118.44 and a median of -$0.47 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned soared 99.94% — and 2025, when it tumbled 397.37%.
- CG Oncology's Times Interest Earned stood at -$238.02 in 2023, then slumped by 166.43% to -$634.15 in 2024, then surged by 62.54% to -$237.56 in 2025, then jumped by 99.93% to -$0.17 in 2026.
- Business Quant data shows CGON's Times Interest Earned at -$0.17 in Q1 2026, -$237.56 in Q4 2025, and -$0.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | CG Oncology | 5.86 Bn | 5.86 Bn | -1.88 Mn | -0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.17 |
| Dec 31, 2025 | -237.56 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.48 |
| Dec 31, 2024 | -634.15 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.10 |
| Sep 30, 2023 | -238.02 |
| Jun 30, 2023 | -273.91 |
| Mar 31, 2023 | -35.87 |